133 related articles for article (PubMed ID: 19147277)
1. The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation.
Raif A; Marshall GM; Bell JL; Koach J; Tan O; D'andreti C; Thomas W; Sekyere E; Norris M; Haber M; Kavallaris M; Cheung BB
Cancer Lett; 2009 May; 277(1):82-90. PubMed ID: 19147277
[TBL] [Abstract][Full Text] [Related]
2. The estrogen-responsive B box protein is a novel regulator of the retinoid signal.
Cheung BB; Bell J; Raif A; Bohlken A; Yan J; Roediger B; Poljak A; Smith S; Lee M; Thomas WD; Kavallaris M; Norris M; Haber M; Liu HL; Zajchowski D; Marshall GM
J Biol Chem; 2006 Jun; 281(26):18246-56. PubMed ID: 16636064
[TBL] [Abstract][Full Text] [Related]
3. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter.
Cheung B; Yan J; Smith SA; Nguyen T; Lee M; Kavallaris M; Norris MD; Haber M; Marshall GM
Int J Cancer; 2003 Jul; 105(6):856-67. PubMed ID: 12767074
[TBL] [Abstract][Full Text] [Related]
5. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells.
Gillespie RF; Gudas LJ
J Mol Biol; 2007 Sep; 372(2):298-316. PubMed ID: 17663992
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.
Qian DZ; Ren M; Wei Y; Wang X; van de Geijn F; Rasmussen C; Nakanishi O; Sacchi N; Pili R
Prostate; 2005 Jun; 64(1):20-8. PubMed ID: 15651062
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway.
Lefebvre B; Brand C; Flajollet S; Lefebvre P
Mol Endocrinol; 2006 Sep; 20(9):2109-21. PubMed ID: 16613989
[TBL] [Abstract][Full Text] [Related]
9. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells.
Urvalek AM; Gudas LJ
J Biol Chem; 2014 Jul; 289(28):19519-30. PubMed ID: 24821725
[TBL] [Abstract][Full Text] [Related]
13. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
14. The retinoid anticancer signal: mechanisms of target gene regulation.
Liu T; Bohlken A; Kuljaca S; Lee M; Nguyen T; Smith S; Cheung B; Norris MD; Haber M; Holloway AJ; Bowtell DD; Marshall GM
Br J Cancer; 2005 Aug; 93(3):310-8. PubMed ID: 16012519
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
16. RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells.
Pozzi S; Rossetti S; Bistulfi G; Sacchi N
Oncogene; 2006 Mar; 25(9):1400-7. PubMed ID: 16261163
[TBL] [Abstract][Full Text] [Related]
17. The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant.
Liu HL; Golder-Novoselsky E; Seto MH; Webster L; McClary J; Zajchowski DA
Mol Endocrinol; 1998 Nov; 12(11):1733-48. PubMed ID: 9817599
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression.
Liu G; Wu M; Levi G; Ferrari N
Int J Cancer; 1998 Oct; 78(2):248-54. PubMed ID: 9754659
[TBL] [Abstract][Full Text] [Related]
20. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]